Search Results Heading

MBRLSearchResults

mbrl.module.common.modules.added.book.to.shelf
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
    Done
    Filters
    Reset
  • Discipline
      Discipline
      Clear All
      Discipline
  • Is Peer Reviewed
      Is Peer Reviewed
      Clear All
      Is Peer Reviewed
  • Reading Level
      Reading Level
      Clear All
      Reading Level
  • Content Type
      Content Type
      Clear All
      Content Type
  • Year
      Year
      Clear All
      From:
      -
      To:
  • More Filters
      More Filters
      Clear All
      More Filters
      Item Type
    • Is Full-Text Available
    • Subject
    • Publisher
    • Source
    • Donor
    • Language
    • Place of Publication
    • Contributors
    • Location
4 result(s) for "Brawley, Otis Webb"
Sort by:
How we do harm : a doctor breaks ranks about being sick in America
Dr. Brawley exposes the underbelly of healthcare today--the under-treatment of the poor, the over-treatment of the rich, the financial conflicts of interests physicians face, insurance that doesn't demand the best (or even cheapest) care, and a pharmaceutical behemoth concerned with selling drugs, not providing health.
Cancer Screening in the United States, 2008: A Review of Current American Cancer Society Guidelines and Cancer Screening Issues
Each year the American Cancer Society (ACS) publishes a summary of its recommendations for early cancer detection and a summary of the most current data on cancer screening rates and trends in US adults. In 2007, the ACS updated its colorectal cancer screening guidelines in a collaborative effort with the US Multi-Society Task Force and the American College of Radiology. In this issue of the journal, we summarize the current ACS guidelines, provide an update of the most recent data pertaining to participation rates in cancer screening from the Centers for Disease Control and Prevention's Behavioral Risk Factor Surveillance System and the National Health Interview Survey, and address some issues related to access to care. [PUBLICATION ABSTRACT]
Boobs : the war on women's breasts
Investigates the controversy swirling around the breast cancer screening test mammography.
Prostate Cancer Screening May Do More Harm Than Good
For two decades, some supporters of prostate cancer screening, even some so-called experts, have overstated, exaggerated and, in some cases, misled the public about the evidence supporting its effectiveness. They downplayed or failed to mention the risks of screening and misapplied and misstated basic principles of cancer screening. The Task Force, an independent board of experts in interpretation of medical evidence, convened by the U.S. Agency for Healthcare Research and Quality, sanctioned true screening experts to review and assess every published scientific study concerning prostate cancer screening. This recently published review is very reasonable. It recognizes that the few studies that suggest that prostate screening saves lives are undermined by biases and inconsistencies. Of course, the studies that did not show a benefit to screening also have flaws. However, all studies consistently show that significant harms are associated with screening and the sometimes unnecessary treatment. Ironically, the Task Force recommendation isn't too far apart from that of the American Urologic Association, which represents most of the doctors who diagnose and treat prostate cancer. The association's 2009 publication titled \"PSA Screening Best Practice\" reads: \"Given the uncertainty that PSA testing results in more benefit than harm, a thoughtful and broad approach to PSA is critical. Patients need to be informed of the risks and benefits of testing before it is undertaken. The risks of overdetection and overtreatment should be included in this discussion.\"